Although nearly equal amounts of people view the Affordable Care Act favorably (43%) as unfavorably (40%), a majority of Americans say they approved of the Supreme Court's decision to continue to allow Americans living in states on the federally facilitated exchange to be eligible for insurance subsidies, according to a recent poll by the Kaiser Family Foundation.
Although nearly equal amounts of people view the Affordable Care Act favorably (43%) as unfavorably (40%), a majority of Americans say they approved of the Supreme Court's decision to continue to allow Americans living in states on the federally facilitated exchange to be eligible for insurance subsidies, according to a recent poll by the Kaiser Family Foundation.
Only 32% say they disapprove of the ruling, while 62% approve the decision to uphold the use of subsidies on HealthCare.gov. Democrats are more likely to approve the decision and Republicans are more likely to disapprove it, but 29% of Republicans admitted to approving of the ruling.
Support for the decision of the most recent challenge to the ACA is higher than the last Court ruling in 2012, which upheld most of the major provisions of the law. At that time, less than half (47%) approved the ruling and 43% disapproved the decision.
However, despite these findngs, 78% of respondents expect this will not end the debate over Obamacare and expect more major battles on the healthcare law in the future. Only 18% think King v. Burwell will be the last challenge. Nearly half (44%) are tired of hearing about the law and believes the country should move on to other issues, but 51% say it is important to continue the debate.
Read more at Kaiser Family Foundation: http://bit.ly/1dz6Irb
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
Decitabine, Venetoclax Combo Boosts Survival in Patients With AML and MDS
May 16th 2024Study findings demonstrate that combining decitabine with venetoclax enhances molecular response rates in patients with acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS), correlating strongly with improved clinical outcomes and overall survival.
Read More